Traditional management of chronic stable angina

Toby C Trujillo1, Paul P Dobesh

  • 1Department of Pharmacy, Boston Medical Center, Northeastern University School of Pharmacy, Boston, Massachusetts 02118, USA.

Pharmacotherapy
|November 29, 2007
PubMed

Insights

Chronic stable angina, a common sign of coronary artery disease (CAD), impacts quality of life and carries risks. Effective management includes symptom relief, lifestyle changes, and risk factor control to prevent major cardiac events.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Geriatrics

Background:

  • Chronic stable angina is an age-related manifestation of coronary artery disease (CAD).
  • Angina significantly reduces quality of life and increases risks of myocardial infarction, heart failure, stroke, and death.
  • Treatment must address symptom relief, quality of life, disease progression, and complication prevention.

Purpose of the Study:

  • To outline comprehensive management strategies for chronic stable angina.
  • To emphasize the dual goals of symptom control and prevention of adverse cardiovascular outcomes.
  • To highlight the role of both pharmacological and interventional treatments, alongside lifestyle modifications.

Main Methods:

  • Instruction on sublingual nitroglycerin for acute anginal episodes.
  • Pharmacological interventions including beta-blockers, calcium channel blockers, long-acting nitrates, and ranolazine for symptom prevention.
  • Aggressive risk factor management, lifestyle changes, antiplatelet agents (e.g., aspirin), and ACE inhibitors for disease modification and event prevention.

Main Results:

  • Medications like beta-blockers and nitrates effectively prevent anginal symptoms.
  • Risk factor modification and lifestyle changes are crucial for preventing disease progression and major adverse cardiac events.
  • Revascularization procedures (PCI or CABG) offer symptom relief and improved prognosis for many patients.
  • Post-revascularization, continued medical therapy and risk factor management are essential.

Conclusions:

  • Comprehensive management of chronic stable angina requires a multi-faceted approach.
  • Integrating pharmacotherapy, lifestyle changes, risk factor control, and potentially revascularization is key.
  • Long-term adherence to treatment and lifestyle modifications is vital for improving patient outcomes and prognosis.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...